Emergent BioSolutions makes the only FDA-approved anthrax vaccine.


Updates from The Motley Fool

Latest updates on Emergent BioSolutions from Fool.com.


Stock Performance

EBS vs. S&P 500 | 2 Year Performance
View Interactive EBS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Emergent BioSolutions.
Current Price: $26.72
Prev Close: $27.06
Open: $26.90
Bid: $26.78
Ask: $26.82
Day's Range: $26.57 - $26.90
52wk Range: $26.53 - $44.38
Volume: 30,362
Avg Vol 577,661
Market Cap: $1.04B
P/E (ttm): 16.40
EPS (ttm): $1.65
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Emergent BioSolutions.
CAPS Rating 4 out of 5
 
480 Outperform
17 Underperform
CAPS All Stars
 
87 Outperform
5 Underperform

How do you think Emergent BioSolutions will perform against the market?



You pick for Emergent BioSolutions is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Daniel J. Abdun-Nabi, CEO

64% Approve

Based on 52 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Emergent BioSolutions.

Emergent BioSolutions makes the only FDA-approved anthrax vaccine.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers